Dimensional Fund Advisors LP Erasca, Inc. Transaction History
Dimensional Fund Advisors LP
- $363 Billion
- Q1 2024
A detailed history of Dimensional Fund Advisors LP transactions in Erasca, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 320,261 shares of ERAS stock, worth $698,168. This represents 0.0% of its overall portfolio holdings.
Number of Shares
320,261
Previous 376,188
14.87%
Holding current value
$698,168
Previous $801,000
17.73%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ERAS
# of Institutions
117Shares Held
74.3MCall Options Held
7.1KPut Options Held
40.1K-
Arch Venture Management, LLC Chicago, IL11.1MShares$24.1 Million33.14% of portfolio
-
Black Rock Inc. New York, NY6.98MShares$15.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.17MShares$13.5 Million0.17% of portfolio
-
Artal Group S.A. Luxembourg, N44.72MShares$10.3 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.34MShares$9.46 Million0.0% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $266M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...